Hashim Hashim Talib, Alhatemi Ahmed Qasim Mohammed, Aji Narjiss, Shah Jaffer
College of Medicine, Warith Al Anbiyaa University, Karbala, Iraq.
Department of Internal Medicine, Al Nasiriyah Teaching Hospital, Thi Qar, Iraq.
SAGE Open Med Case Rep. 2024 Jul 23;12:2050313X241265072. doi: 10.1177/2050313X241265072. eCollection 2024.
This study examines the contraindications of gabapentin and Nucleo C.M.P Forte in metformin-controlled diabetic patients, focusing on their potential to induce hyperglycemia. A case report of a 65-year-old woman with type II diabetes is presented, demonstrating elevated blood glucose levels following the initiation of gabapentin and Nucleo C.M.P Forte. The literature review highlights limited data on gabapentin-induced hyperglycemia, with additional consideration of the potential effects of Nucleo C.M.P Forte. The study suggests modifying insulin therapy in diabetic patients taking gabapentin and calls for further research on this interaction.
本研究探讨加巴喷丁和强力核甘酸（Nucleo C.M.P Forte）在二甲双胍控制的糖尿病患者中的禁忌证，重点关注它们诱发高血糖的可能性。本文呈现了一例65岁2型糖尿病女性的病例报告，显示在开始服用加巴喷丁和强力核甘酸后血糖水平升高。文献综述强调了关于加巴喷丁诱发高血糖的有限数据，并额外考虑了强力核甘酸的潜在影响。该研究建议调整服用加巴喷丁的糖尿病患者的胰岛素治疗方案，并呼吁对这种相互作用进行进一步研究。
